This is what the one up the road will be starting out with as far as stock. Flowers and concentrates might vary some over the flowers but we'll see. Im excited
Blue Dream
Blueberry Diesel
Bubba Kush
Cannatonic
MJardin CBD
Durban Poison
Knockout Kush
Golden Goat
Granddaddy Purps
Harlequin
Jack Flash
Grandpa Abe
Purple Pineapple Kush
Fruity Pebbles OG
Maui Wowie OG
CBD Therapy
Platinum Cookies
Sour Diesel
Maui Crush
These strains provide a varied mix of cannabinoid contents as well as species (indica, sativa, indica dominant hybrids, sativa dominant hybrids, and 50/50 hybrids). Specifically, Cannatonic, MJardin CBD, and Harlequin are higher in cannabidiol (CBD) content than most cannabis strains. Cannabidiol (CBD) is a promising nonpsychoactive constituent widely accepted in medical and non-medical communities for minimizing chronic pain, seizures, and epilepsy. CBD blocks and stabilizes excitatory receptors such as NMDA, the over-reactive receptors in most epileptic conditions. A potent anti-inflammatory, anti-spasmodic, and neuro-protective substance, CBD dramatically reduces anxiety without affecting mental processes. CBD is well known for providing relaxation without sedation and relief without intoxication. We will offer products based on the following high-CBD strains:
While we plan to offer a wide variety of strains with varying THC and CBD levels we cannot guarantee which strains these will be as we are dependent upon what strains are offered by Maryland Growers.
Cannatonic
with nearly a 1:1 ratio of THC to CBD (CBD up to 24% by weight), is not particularly psychoactive as a daytime analgesic and anti-inflammatory medicine. It contains significant amounts of cannabigerol (CBG), known to play roles in reducing inflammation, inhibiting cell growth in tumor/cancer cells, and promoting bone growth. Cannatonic also contains higher proportions of beta-myrcene, known to provide more sedative effects, than typical strains.
Harlequin
with a 2:5 ratio of THC to CBD (up to 16% CBD by weight), is not a psychoactive medicine and provides treatment for pain and anxiety. It contains lower amounts of CBG but higher amounts of cannabichromene (CBC), also known to be involved in pain and inflammation reduction.
In addition to our cannabis flower product offerings, we will offer our patients medical cannabis extracts, both in liquid (oil) and solid (crystalline, wax) forms, ideally processed using carbon dioxide extraction processes. The solvent capacity of carbon dioxide can be tuned to selectively extract specific cannabinoid contents over others, providing another mechanism for tuning the composition of the final medical product. The resulting cannabis extracts range from 30-75% cannabinoids by weight. This concentration can be increased by simple physical and mechanical purification methods. Utilizing a food-grade solvent , e.g. organic cane-sugar-derived 200 proof alcohol, in conjunction with carbon dioxide solvent-tuning methods can yield extract products reaching as high as 90% cannabinoids by weight.
The extracts generated from both THC-dominant and CBD-dominant strains of medical cannabis have been used in studies (
http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php) demonstrating their impact on and treatment of pain and inflammation reduction, multiple sclerosis, seizures, cancer, epilepsy, HIV, nausea, and glaucoma, among others.
We will continue to monitor research associated with chemical compositions and their effects on medical conditions to best identify products that address our patients’ medical conditions.